We are live on ! Find out more
RCM

Riverhead Capital Management Portfolio holdings

AUM $2.71B
1-Year Est. Return 2.34%
This Fund
S&P 500
This Quarter Est. Return
+1.42%
1 Year Est. Return
+2.34%
3 Year Est. Return
+45.7%
5 Year Est. Return
+71.11%
10 Year Est. Return
AUM
$2.71B
AUM Growth
-$3.34M
Cap. Flow
-$19.3M
Cap. Flow %
-0.71%
Top 10 Hldgs %
12.6%
Holding
1,579
New
62
Increased
514
Reduced
352
Closed
83

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$20.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$9.12M
3
MSFT icon
Microsoft
MSFT
+$7.23M
4
T icon
AT&T
T
+$6.88M
5
C icon
Citigroup
C
+$6.4M

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$7.59M
2
RHI icon
Robert Half
RHI
+$7.08M
3
FTNT icon
Fortinet
FTNT
+$6.33M
4
ALLY icon
Ally Financial
ALLY
+$5.86M
5
FFIV icon
F5
FFIV
+$4.64M

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Financials 14.81%
3 Healthcare 13.01%
4 Industrials 10.94%
5 Consumer Discretionary 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUTH
1451
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$35K ﹤0.01%
+1,700
New +$35.4K
FTAI icon
1452
FTAI Aviation
FTAI
$21.6B
$33K ﹤0.01%
2,518
KGC icon
1453
Kinross Gold
KGC
$28B
$33K ﹤0.01%
7,421
+600
+9% +$2.79K
MCS icon
1454
Marcus Corp
MCS
$727M
$33K ﹤0.01%
+900
New +$31K
CCJ icon
1455
Cameco
CCJ
$38.6B
$32K ﹤0.01%
3,500
MDB icon
1456
MongoDB
MDB
$24.7B
$32K ﹤0.01%
266
TFIN icon
1457
Triumph Financial Inc
TFIN
$1.89B
$29K ﹤0.01%
+900
New +$27.1K
CAE icon
1458
CAE Inc
CAE
$7.86B
$27K ﹤0.01%
1,104
BBIO icon
1459
BridgeBio Pharma
BBIO
$16.1B
$25K ﹤0.01%
+1,183
New +$32.7K
SPNT icon
1460
SiriusPoint
SPNT
$2.88B
$23K ﹤0.01%
+2,300
New +$23.1K
VET icon
1461
Vermilion Energy
VET
$1.56B
$23K ﹤0.01%
1,400
ALNY icon
1462
Alnylam Pharmaceuticals
ALNY
$36.2B
$22K ﹤0.01%
270
EAF icon
1463
GrafTech
EAF
$170M
$22K ﹤0.01%
+170
New +$20.2K
PLAB icon
1464
Photronics
PLAB
$1.85B
$22K ﹤0.01%
+2,000
New +$19.3K
SAGE
1465
DELISTED
Sage Therapeutics
SAGE
$22K ﹤0.01%
156
MEOH icon
1466
Methanex
MEOH
$4.27B
$20K ﹤0.01%
579
ATYR
1467
aTyr Pharma
ATYR
$47.6M
$20K ﹤0.01%
5,784
+93
+2% +$343
CUTR
1468
DELISTED
Cutera, Inc.
CUTR
$20K ﹤0.01%
+700
New +$19.2K
ANDE icon
1469
Andersons Inc
ANDE
$2.65B
$18K ﹤0.01%
+800
New +$20.3K
HT
1470
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$18K ﹤0.01%
+1,200
New +$18.3K
BDN
1471
Brandywine Realty Trust
BDN
$547M
$17K ﹤0.01%
1,100
-1,653
-60% -$24.1K
BKU icon
1472
Bankunited
BKU
$3.49B
$17K ﹤0.01%
+500
New +$16.3K
BB icon
1473
BlackBerry
BB
$5.27B
$15K ﹤0.01%
2,900
CYBR
1474
DELISTED
CyberArk
CYBR
$15K ﹤0.01%
+150
New +$18.1K
ESLT icon
1475
Elbit Systems
ESLT
$36.3B
$15K ﹤0.01%
100

Similar funds

Riverhead Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Riverhead Capital Management held 1,579 positions worth $2.71B, down 0.12% from $2.71B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Riverhead Capital Management's Q3 2019 filing shows 62 new, 514 increased, 352 reduced and 83 closed positions. Its largest new stake was iShares Russell 2000 ETF: 132,000 shares worth $20M. The largest sale was MetLife, an estimated $7.59M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Riverhead Capital Management's largest Q3 2019 buy was iShares Russell 2000 ETF: 132,000 shares worth $20M.
  • Riverhead Capital Management added most to Johnson & Johnson in Q3 2019, an estimated $9.12M increase.
  • Riverhead Capital Management's biggest Q3 2019 reduction was MetLife, cutting an estimated $7.59M.
  • Riverhead Capital Management fully exited Booz Allen Hamilton in Q3 2019, selling an estimated $1.68M.
  • Riverhead Capital Management's ten largest holdings make up 13% of its $2.71B portfolio in Q3 2019.
  • Riverhead Capital Management opened 62 new positions and closed 83 in Q3 2019.
  • Riverhead Capital Management's portfolio value fell 0.12% quarter-over-quarter to $2.71B.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.